Further evidence linking urolithiasis and blood coagulation: Urinary prothrombin fragment 1 is present in stone matrix

Kidney International

Volumn 49, Issue 3, 1996, Pages 880-888

  Stapleton, Alan M F ^a,b   Dawson, Caroline J ^a   Grover, Phulwinder K ^a   Hohmann, Art ^a   Comacchio, Raffaela ^a   Boswarva, Vicki ^a   Tang, Yulu ^a   Ryall, Rosemary L ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; MONOCLONAL ANTIBODY; PROTHROMBIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UROLITHIASIS;

EID: 0029923933     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.121     Document Type: Article

References (37)

1. YOSHIDA O, OKADA Y: Epidemiology of urolithiasis in Japan: A chronological and geographical study. Urol Int 45:104-111, 1990
2. KOHRI K, ISHIKAWA Y, KATOH Y, KATAOKA K, IGUCHI M, YACHIKU S, KURITA T: Epidemiology of urolithiasis in the elderly. Int Urol Nephrol 23:413-421, 1991
3. KING JS, BOYCE WH: Analysis of renal calculous matrix compared with some other matrix materials and with uromucoid. Arch Biochem Biophys 82:455-461, 1959
4. WARPEHOSKI MA, BUSCEMI PJ, OSBORN DC, FINLAYSON B, GOLDBERG EP: Distribution of organic matrix in calcium oxalate renal calculi. Calcif Tissue Int 33:211-222, 1981
5. BOYCE WH, GARVEY FK: The amount and nature of the organic matrix in urinary calculi: A review. J Urol 76:213-227, 1956
6. DOYLE IR, RYALL RL, MARSHALL VR: Inclusion of proteins into calcium oxalate crystals precipitated from human urine: A highly selective phenomenon. Clin Chem 37:1589-1594, 1991
7. IWATA H, KAMEI O, ABE Y, NISHIO S, WAKATSUKI A, OCHI K, TAKEUCHI M: The organic matrix of urinary uric acid crystals. J Urol 139:607-610, 1988
8. MORSE RM, RESNICK MI: A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 139:869-873, 1988
9. MORSE RM, RESNICK MI: A study of the incorporation of urinary macromolecules onto crystals of different mineral compositions. J Urol 141:641-644, 1989
10. STAPLETON AMF, SIMPSON RJ, RYALL RL: Crystal matrix protein is related to human prothrombin. Biochem Biophys Res Commun 195: 1199-1203, 1993
11. STAPLETON AMF, RYALL RL: Blood coagulation proteins and urolithiasis are linked: Crystal matrix protein is the F1 activation peptide of human prothrombin. Br J Urol 75:712-719, 1995
12. RYALL RL, GROVER PK, STAPLETON AMF, BARRELL DK, TANG Y, MORITZ RL, SIMPSON RJ: The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted urine in vitro. Clin Sci 89:533-541, 1995
13. SUZUKI K, MORIYAMA M, NAKAJIMA C, KAWAMURA K, MIYAZAWA K, TSUGAWA R, KIKUCHI N, NAGATA K: Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: Evidence of activation peptide of human prothrombin. Urol Res 22:45-50, 1994
14. GODING JW: Antibody production by hybridomas. J Immunol Meth 39:285-308, 1980
15. ZOLA H: Monoclonal Antibodies: A Manual of Techniques. Boca Raton, CRC Press, 1987, p 214
16. KEARNEY JF, RADBRUCH A, LIESEGANG B, RAJEWSKY K: A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 123:1548-1550, 1979
17. RIGHETTI PG, TUDOR G: Isoelectric points and molecular weights of proteins. A new table. J Chromatogr 220:115-194, 1981
18. STAPLETON AMF: Crystal Matrix Protein and Urolithiasis: Getting Blood Out of a Stone. PhD thesis, Flinders University of South Australia, 1995
19. STAPLETON AMF, SEYMOUR AE, BRENNAN JS, DOYLE IR, MARSHALL VR, RYALL RL: The immunohistochemical distribution and quantification of crystal matrix protein. Kidney Int 44:817-824, 1993
20. LAEMMLI UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
21. TOWBIN H, STAEHELIN T, GORDON J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
22. FARRINGTON CJ, LIDDY ML, CHALMERS AH: A simplified sensitive method for the analysis of renal calculi. Am J Clin Pathol 73:96-99, 1980
23. HSU S, SOBAN E: Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 30:1079-1082, 1982
24. FRIEZNER DEGEN SJ, DAVIE EW: Nucleotide sequence of the gene for human prothrombin. Biochemistry 26:6165-6177, 1987
25. ROMBERG RW, WERNESS PG, RIGGS BL, MANN KG: Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 25:1176-1180, 1986
26. OGASAWARA K, VAN RR, AKO H: γ-Carboxyglutamic acid, a component in human pediatric bladder stones containing calcium salts. J Urol 137:349-352, 1987
27. ADDADI L, WEINER S: Interactions between acidic proteins and crystals: Stereochemical requirements in biomineralization. Proc Natl Acad Sci USA 82:4110-4114, 1985
28. ADDADI L, WEINER S: Interactions between acidic macromolecules and structured crystal surfaces. Stereochemistry and biomineralization. Mol Cryst Liq Cryst 134:305-322, 1986
29. JOHRDE LG, COCKS FH: Effect of pH on the microhardness of renal calculi. J Biomed Mater Res 20:945-950, 1986
30. GARCIA RA, CONTE A, GRASES F: The origin and causes of struvite stones. Int Urol Nephrol 23:537-542, 1991
31. GAULT MH, CHAFE LL, MORGAN JM, PARFREY PS, HARNETT JD, WALSH EA, PRABHAKARAN VM, DOW D, COLPITTS A: Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine Baltimore 70:345-359, 1991
32. LIAN JB, PRIEN EL JR, GLIMCHER MJ, GALLOP PM: The presence of protein-bound γ- carboxyglutamic acid in clacium-containing renal calculi. J Clin Invest 59:1151-1157, 1977
33. BEZEAUD A, GUILLIN M-C: Quantitation of prothrombin activation products in human urine. Br J Haematol 58:597-606, 1984
34. SØRENSEN JV, JENSEN HP, RAHR HB, BORRIS LC, LASSEN MR, KNUDSEN F: F1 + 2 and FpA in urine from patients with multiple trauma and healthy individuals. A pilot study. Thromb Res 67:429-434, 1992
35. KOHRI K, NOMURA S, KITAMURA Y, NAGATA T, YOSHIOKA K, IGUCHI M, YAMATE T, UMEKAWA T, SUZUKI Y, SINOHARA H, KURITA T: Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184, 1993
36. SHIRAGA H, MIN W, VANDUSEN WJ, CLAYMAN MD, MINER D, TERRELL CH, SHERBOTIE JR, FOREMAN JW, PRZYSIECKI C, NEILSON EG, HOYER JR: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430, 1992
37. NAKAGAWA Y, AHMED M, HALL SL, DEGANELLO S, COE FL: Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carhoxyglutamic acid. J Clin Invest 79:1782-1787, 1987